Utilization of innovative medical technologies in German inpatient care: does evidence matter?

ABSTRACT:

Background

The reimbursement of new technologies in inpatient care is not always linked to a requirement for evidence-based evaluation of patient benefit. In Germany, every new technology approved for market was until recently eligible for reimbursement in inpatient care unless explicitly excluded. The aim of this work was (1) to investigate the type of evidence that was available at the time of introduction of 25 innovative technologies and how this evidence evolved over time, and (2) to explore the relationship between clinical evidence and utilization for these technologies in German inpatient care.

Methods

This study combined different methods. A systematic search for evidence published between 2003 and 2017 was conducted in four bibliographic databases, clinical trial r

SUBMITTER: Eckhardt H 

PROVIDER: S-EPMC10546629 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature